MEGESTROL

Course overview

MEGESTROL IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME. IT IS IN THE PROGESTIN CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR MEGESTROL AS A VALUABLE AGENT IN THE MANAGEMENT OF SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS INCLUDING OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, AND MONITORING, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS WITH SIGNIFICANT, INEXPLICABLE WEIGHT LOSS IN HIV/AIDS PATIENTS AND ANOREXIA OR CACHEXIA SYNDROME, AND RELATED CONDITIONS.